Published in:
01-12-2020 | Diabetes | Research article
Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study
Authors:
Sepideh Babaniamansour, Ehsan Aliniagerdroudbari, Mahtab Niroomand
Published in:
Journal of Diabetes & Metabolic Disorders
|
Issue 2/2020
Login to get access
Abstract
Purpose
Detection and modification of various factors such as life style, smoking and so on can significantly improve the glycemic control status. This study aimed to investigate glycemic control status and its relevant factors among patients with Type 2 DM.
Methods
In this cross-sectional study, the glycemic control status of patients with type 2 DM was investigated. In addition, relevant risk factors including demographic, clinical characteristics, self-care management behavior, medication adherence and laboratory data and their relationship with glycemic control status were assessed. Glycemic control status was defined as very good (HbA1c < 7%), good (HbA1c = 7–7.9%), poor (HbA1c = 8–9.9%) or extremely bad (HbA1c ≥ 10%).
Results
The present study included 562 patients (64.4% female). Most of the patients (37%) had poor glycemic control status. Microvascular complications especially diabetic neuropathy were the most common complications in our study. Glycemic control had significant relationship with level of education (p < .01) and occupation (p = .04). Among laboratory parameters, fasting plasma glucose (FPG) and total cholesterol levels were significantly lower in patients with desirable glycemic control (p < .05). The linear regression test showed that HbA1c had significant relationship with FPG (p < .01) and increasing one standard deviation in FPG can increase the level of HbA1c 0.014.
Conclusion
Glycemic control status in our study was very low and FPG was the strongest predictor of glycemic control status. Some other factors were also associated such as education level, occupation, type of treatment, diastolic blood pressure, the lipid profile and aspartate transaminase.